|
2024
|
Invention
|
Chimeric proteins comprising masked il-2. Provided herein are IL-2 prodrugs, as well as methods o... |
|
|
Invention
|
Novel cytokine prodrugs.
Provided herein are cytokine muteins and cytokine prodrugs and methods ... |
|
|
Invention
|
Novel angiopoietin 2, vegf dual antagonists.
The present disclosure relates to fusion molecules ... |
|
2023
|
Invention
|
Mutant il-2 polypeptides and il-2 prodrugs. Provided herein are IL-2 mutants, IL-2 prodrugs, and ... |
|
|
Invention
|
Novel il-15 prodrugs and methods of use thereof.
Provided herein are IL-15 cytokine prodrugs and... |
|
|
Invention
|
Novel angiopoietin 2, vegf dual antagonists.
The present disclosure relates to chimeric molecule... |
|
2022
|
Invention
|
Antibodies and methods for making and using the same. Described and provided herein are novel ant... |
|
|
Invention
|
Il-2 receptor beta subunit mutants. The present disclosure provides novel interleukin-2 receptor ... |
|
|
Invention
|
Chimeric molecules comprising an il-10 or tgf-beta agonist polypeptide.
The present disclosure r... |
|
|
Invention
|
Chimeric molecules comprising an il-10 or tgf-beta agonist polypeptide. The present disclosure re... |
|
|
Invention
|
Interferon prodrugs and methods of making and using the same.
Provided herein are interferon pro... |
|
|
Invention
|
Interferon prodrugs and methods of making and using the same. Provided herein are interferon prod... |
|
|
Invention
|
Chimeric molecules comprising il-12 agonist polypeptide.
The present application relates to nove... |
|
|
Invention
|
Chimeric molecules comprising il-12 agonist polypeptide. The present application relates to novel... |
|
2021
|
Invention
|
Angiopoietin 2, vegf dual antagonists. The present disclosure relates to fusion molecules and chi... |
|
|
Invention
|
Human tigit specific single domain antibodies and methods of use. The present invention provides ... |
|
|
Invention
|
Novel masked cytokines and methods of use thereof.
Provided herein are prodrugs and methods of m... |
|
|
Invention
|
Novel masked cytokines and methods of use thereof. Provided herein are prodrugs and methods of ma... |
|
2020
|
Invention
|
Cytokine prodrugs and dual-prodrugs.
The present application relates to novel prodrugs of IL-12.... |
|
|
Invention
|
Cytokine prodrugs and dual-prodrugs. The present application relates to novel prodrugs of IL-12. ... |
|
|
Invention
|
Novel il-21 prodrugs and methods of use thereof.
Provided herein are IL-21 prodrugs and methods ... |
|
|
Invention
|
Novel il-21 prodrugs and methods of use thereof. Provided herein are IL-21 prodrugs and methods o... |
|
|
Invention
|
Il-2 fusion proteins that preferentially bind il-2ralpha.
The present disclosure provides novel ... |
|
|
Invention
|
Novel il-2 fusion molecules. The present disclosure provides novel isolated IL-2 fusion molecules... |
|
|
Invention
|
Il-2 fusion proteins that preferentially bind il-2ralpha. in vitroin vivo.in vivo. Further includ... |
|
|
Invention
|
Novel il-15 prodrugs and methods of use thereof. Provided herein are IL-15 cytokine prodrugs and ... |
|
|
Invention
|
Il-15 prodrugs and methods of use thereof. Provided herein are IL-15 cytokine prodrugs and method... |
|
|
Invention
|
Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis. The present invention r... |
|
|
Invention
|
Angiopoietin 2, vegf dual antagonists. The present disclosure relates to chimeric molecules which... |
|
2019
|
Invention
|
Novel antibodies and methods for making and using the same. |
|
|
Invention
|
Novel feline erythropoietin receptor agonists.
The present specification discloses erythropoieti... |
|
|
Invention
|
Pharmaceutical formulations for novel feline erythropoietin receptor agonists.
The present speci... |
|
|
Invention
|
Pharmaceutical formulations for novel feline erythropoietin receptor agonists. |
|
|
Invention
|
Novel angiopoietin 2, vegf dual antagonists. |
|
|
Invention
|
Novel cytokine prodrugs. Provided herein are cytokine muteins and cytokine prodrugs and methods o... |
|
|
Invention
|
Cytokine prodrugs. Provided herein are cytokine muteins and cytokine prodrugs and methods of maki... |
|
|
Invention
|
Novel antibody-drug conjugates (adc), methods of making, and methods of use thereof. Described he... |
|
2018
|
Invention
|
Pd-l1 specific monoclonal antibodies for disease treatment and diagnosis.
The present invention ... |
|
2017
|
Invention
|
Novel antibody-albumin-drug conjugates (aadc) and methods for using them.
The present invention ... |
|
|
Invention
|
Novel antibody-albumin-drug conjugates (aadc) and methods for using them. The present invention r... |
|
|
Invention
|
Fusion protein comprising leptin and methods for producing and using the same.
The present inven... |
|
|
Invention
|
Fusion protein comprising leptin and methods for producing and using the same. The present invent... |
